Eurofins-Cerep SA (EPA: ALECR)
France
· Delayed Price · Currency is EUR
19,600
0.00 (0.00%)
Jan 7, 2025, 5:24 PM CET
Eurofins-Cerep Revenue
In the year 2023, Eurofins-Cerep had annual revenue of 44.07M EUR, down -7.51%. Eurofins-Cerep had revenue of 24.64M in the half year ending December 31, 2022, with 41.09% growth.
Revenue
44.07M
Revenue Growth
+0.85%
P/S Ratio
n/a
Revenue / Employee
193.30K
Employees
228
Market Cap
98.86M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 44.07M | -3.58M | -7.51% |
Dec 31, 2022 | 47.65M | 6.01M | 14.45% |
Dec 31, 2021 | 41.63M | 8.97M | 27.45% |
Dec 31, 2020 | 32.67M | 1.66M | 5.35% |
Dec 31, 2019 | 31.01M | 5.56M | 21.83% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech | 2.74B |
bioMérieux | 3.81B |
Ipsen | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac | 1.34B |
Ramsay Générale de Santé | 5.01B |